Literature DB >> 26440692

Long-term neurofunctional outcome, executive functioning, and behavioral adaptive skills following fetal myelomeningocele surgery.

Enrico Danzer1, Nina H Thomas2, Allison Thomas2, Karen B Friedman2, Marsha Gerdes2, Jamie Koh2, N Scott Adzick2, Mark P Johnson2.   

Abstract

BACKGROUND: Myelomeningocele (MMC) represents the first nonlethal anomaly to be treated by prenatal intervention. Case series and a prospective, randomized study show that fetal surgery for MMC before 26 weeks' gestation may preserve neurological function. Long-term follow-up is a fundamental component to evaluate the overall efficacy of any new medical or surgical procedure. To further delineate the long-term impact of fMMC surgery, we continued to follow children treated in our institution before the Management of Myelomeningocele Study trial by the means of parental questionnaires to assess changes in functional, developmental, and cognitive status as these unique patients grow older.
OBJECTIVE: The objective of the study was to evaluate the long-term neurological outcome, executive functioning (EF), and behavioral adaptive skills (BAS) following fetal myelomeningocele (fMMC) surgery. STUDY
DESIGN: Prior to the Management of Myelomeningocele Study trial, 54 patients underwent fMMC surgery at our institution. Parents of 42 children (78%) participated in structured questionnaires focusing on neurofunctional outcome. EF and BAS were measured by the Behavior Rating Inventory of Executive Function (BRIEF) and the Adaptive Behavioral Assessment System II. The BRIEF is organized into 3 primary indices including the following: Global Executive Composite, Metacognition Index, and Behavioral Regulation Index. The Adaptive Behavioral Assessment System II results in a general adaptive composite score. Based on SD intervals, EF and BAS were categorized as being average, borderline, or impaired.
RESULTS: At a median follow-up age of 10 years (range, 8-14 years), 33 (79%) are community ambulators, 3 (9%) are household ambulators, and 6 (14%) are wheelchair dependent. Preschool ambulation was predictive of long-term ambulation (P < .01), whereas the need for tethered cord surgery was associated with persistent deterioration of ambulatory status (P = .007). Normal bladder function was found in 26%. Although the majority scored within the average range for the Behavioral Regulation Index, Metacognition Index, and Global Executive Composite indices, significantly more children who had fMMC surgery had deficits in EF in all 3 BRIEF indices compared with the population norms. The general adaptive composite scores were also more likely to fall below average following fMMC surgery. Normal early neurodevelopmental outcomes were predictive of normal EF and BAS (P < .01). Need for shunting was associated with a significant impairment of BAS (P = .02).
CONCLUSION: The present study suggests that fMMC surgery improves long-term functional outcome. The majority of fMMC children can successfully complete everyday tasks at home and at school. Abnormalities of BAS appear to be more common than impairments in EF and therefore offer an area for early screening and interventional therapy for these at-risk children. Non-shunted fMMC children with normal early neurodevelopmental outcome are less likely to experience problems with EF and BAS. fMMC surgery improves long-term ambulatory status. Symptomatic spinal cord tethering with or without intradural inclusion cyst is associated with functional loss. More than expected fMMC children are continent, but bowel and bladder control continue to be an ongoing challenge for the fMMC children.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adaptive Behavioral Assessment System; Behavior Rating Inventory of Executive Function; fetal surgery; myelomeningocele; neuromotor function

Mesh:

Year:  2015        PMID: 26440692     DOI: 10.1016/j.ajog.2015.09.094

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  New directions in fetal surgery for myelomeningocele.

Authors:  Sandra K Kabagambe; Y Julia Chen; Melissa A Vanover; Payam Saadai; Diana L Farmer
Journal:  Childs Nerv Syst       Date:  2017-05-11       Impact factor: 1.475

2.  Low level myelomeningoceles: do they need prenatal surgery?

Authors:  Pierre-Aurelien Beuriat; Isabelle Poirot; Frederic Hameury; Delphine Demede; Kieron J Sweeney; Alexandru Szathmari; Federico Di Rocco; Carmine Mottolese
Journal:  Childs Nerv Syst       Date:  2019-03-27       Impact factor: 1.475

3.  The Construction of a Predictive Composite Index for Decision-Making of CSF Diversion Surgery in Pediatric Patients following Prenatal Myelomeningocele Repair.

Authors:  F T Mangano; M Altaye; C B Stevenson; W Yuan
Journal:  AJNR Am J Neuroradiol       Date:  2022-07-28       Impact factor: 4.966

4.  Amniotic fluid transcriptomics reflects novel disease mechanisms in fetuses with myelomeningocele.

Authors:  Tomo Tarui; Aimee Kim; Alan Flake; Lauren McClain; John D Stratigis; Inbar Fried; Rebecca Newman; Donna K Slonim; Diana W Bianchi
Journal:  Am J Obstet Gynecol       Date:  2017-07-20       Impact factor: 10.693

Review 5.  Prenatal surgery for myelomeningocele: review of the literature and future directions.

Authors:  Gregory G Heuer; Julie S Moldenhauer; N Scott Adzick
Journal:  Childs Nerv Syst       Date:  2017-05-17       Impact factor: 1.475

Review 6.  Fetal myelomeningocele repair: a narrative review of the history, current controversies and future directions.

Authors:  Kaeli J Yamashiro; Diana L Farmer
Journal:  Transl Pediatr       Date:  2021-05

7.  Towards Guideline-Based Management of Tethered Cord Syndrome in Spina Bifida: A Global Health Paradigm Shift in the Era of Prenatal Surgery.

Authors:  Viachaslau Bradko; Heidi Castillo; Shruthi Janardhan; Benny Dahl; Kellen Gandy; Jonathan Castillo
Journal:  Neurospine       Date:  2019-07-08

Review 8.  Fetal surgery for open spina bifida.

Authors:  Adalina Sacco; Fred Ushakov; Dominic Thompson; Donald Peebles; Pranav Pandya; Paolo De Coppi; Ruwan Wimalasundera; George Attilakos; Anna Louise David; Jan Deprest
Journal:  Obstet Gynaecol       Date:  2019-09-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.